首页|OGDHL、FHL1在非小细胞肺癌组织中的表达及其临床意义

OGDHL、FHL1在非小细胞肺癌组织中的表达及其临床意义

扫码查看
目的 分析OGDHL、4 个半LIM结构域蛋白1(FHL1)在非小细胞肺癌组织中的表达水平及其临床意义.方法 选取80 例非小细胞肺癌患者癌组织标本、癌旁组织标本(距肿瘤边缘4cm处),采用免疫组织化学染色法检测所有标本组织中OGDHL、FHL1 表达水平.采用x2 检验分析OGDHL、FHL1 表达与患者病理特征的关系,采用 Kaplan-Meier生存曲线分析OGDHL、FHL1 表达与患者预后的关系,多因素Cox回归模型分析非小细胞肺癌患者预后的影响因素.结果 非小细胞肺癌患者癌组织OGDHL高表达率明显低于癌旁组织(35.00%vs 62.50%,P<0.05),FHL1 高表达率明显高于癌旁组织(67.50%vs 40.00%,P<0.05).OGDHL、FHL1 表达水平与非小细胞肺癌患者TNM分期、淋巴结转移、分化程度密切相关(P<0.05).OGDHL高表达患者术后5 年总生存率为82.14%,低表达患者术后5 年总生存率为36.54%,两者比较差异有统计学意义(P<0.05);FHL1 高表达患者术后5 年总生存率为40.74%,低表达患者术后5 年总生存率为76.92%,两者比较差异有统计学意义(P<0.05).单因素分析得出,TNM分期、淋巴结转移、分化程度、OGDHL表达、FHL1 表达均与非小细胞肺癌患者预后密切相关(P<0.05).TNM Ⅲ期、淋巴结转移、低分化、OGDHL低表达、FHL1 高表达均为影响非小细胞肺癌患者预后的独立危险因素(P<0.05).结论 非小细胞肺癌患者癌组织中OGDHL蛋白呈低表达,FHL1 蛋白呈高表达,两者表达水平与非小细胞肺癌患者的临床病理特征及预后密切相关,能够作为评估患者预后的有效指标.
Expression of OGDHL and FHL1 in Non-small Cell Lung Cancer and Its Clinical Significance
Objective To explore the expression levels and clinical significance of OGDHL and four half-LIM domain protein 1(FHL1)in non-small cell lung cancer tissues.Methods The cancer tissue specimens and paracancerous tissue speci-mens(4 cm from the tumor edge)of 80 cases with non-small cell lung cancer were selected,and then immunohistochemical stai-ning was used to detect the expression levels of OGDHL and FHL1 in all specimens.The x2 test was used to analyze the relation-ship between the expression of OGDHL,FHL1 and the pathological characteristics of cases with non-small cell lung cancer,and the Kaplan-Meier survival curve was used to analyze the relationship between the expression of OGDHL and FHL1 and the prog-nosis of cases,and multivariate Cox regression model was used to analyze the influence factors of the prognosis of cases with non-small cell lung cancer.Results The high expression rate of OGDHL in cancer tissue of cases with non-small cell lung cancer was lower than that in adjacent tissue(35.00%vs62.50%,P<0.05),and the high expression rate of FHL1 was higher than that in adjacent tissue(67.50%vs 40.00%,P<0.05).The expression levels of OGDHL and FHL1 were closely related to the TNM stage,lymph node metastasis and differentiation degree of cases with non-small cell lung cancer(P<0.05).The5-year overall survival rate of cases with high OGDHL expression after operation was82.14%,and the5-year overall survival rate of cases with low expression of OGDHL after operation was 36.54%(P<0.05).The 5-year overall survival rate of cases with high OGDHL ex-pression was40.74%,and the5-year overall survival rate of the patients with low expression after operation was 76.92%(P<0.05).TNM stage,lymph node metastasis,degree of differentiation,OGDHL expression and FHL1 expression were closely related to the prognosis of patients with non-small cell lung(P<0.05).TNM stage Ⅲ,lymph node metastasis,poor differentiation,low expression of OGDHL and high expression of FHL1 were independent risk factors for the prognosis of cases with non-small cell lung cancer(P<0.05).Conclusion The expression of OGDHL protein in the cancer tissue of cases with non-small cell lung cancer is low,and the expression of FHL1 protein is high.The expression levels of the 2 are closely related to the clinicopathologi-cal characteristics and prognosis of cases with non-small cell lung cancer.They can be used as effective indicators for evaluating the prognosis of cases.

Non-small cell lung cancerOGDHL4 half-LIM domain protein 1Prognosis

张春晓、张群妹、鲁广建

展开 >

453100 新乡医学院第一附属医院

非小细胞肺癌 OGDHL 4个半LIM结构域蛋白1 预后

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(2)
  • 6